Trade DISC MEDICINE ORD - IRON
Disc Medicine, Inc. (NASDAQ: IRON) is a clinical-stage biopharmaceutical company developing therapies for hematologic diseases caused by dysregulated iron homeostasis. Its pipeline targets both rare and chronic blood disorders with novel mechanisms of action. Disc Medicine’s shares move with clinical trial results, regulatory updates, and investor sentiment toward innovative rare-disease treatments.Latest shares articles

Uber Technologies stock forecast: 3,300 job cuts, robotaxi push
Uber is cutting around 3,300 jobs as part of a restructuring, while expanding its autonomous-vehicle partnerships amid growing competition in the robotaxi market. Explore third-party UBER price targets and technical analysis. Past performance is not a reliable indicator of future results.
3 hours ago

Cellnex stock forecast: BlackRock raises stake to 6.398%
Cellnex Telecom is a European telecom-infrastructure company listed in Madrid. In September, BlackRock raised its stake to 6.398% as Cellnex continued its share-buyback programme. Explore third-party CNLX price targets Past performance is not a reliable indicator of future results.
13:15, 28 September 2026

Siemens stock forecast: VinSpeed high-speed rail contract
Siemens is a German industrial group with businesses across automation, infrastructure and mobility. On 22 September 2026, Siemens Mobility signed a high-speed rail contract with VinSpeed. Explore third-party SIE price targets. Past performance is not a reliable indicator of future results.
12:07, 28 September 2026

DeFi Technologies stock forecast: Valour hedge fund launch
DeFi Technologies' subsidiary Valour launched its first hedge fund on 21 September 2026, expanding the business beyond exchange-traded products. Explore third-party DEFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:22, 28 September 2026
Related News
GlobeNewswire•Europe
Newsfile•Europe
GlobeNewswire•Europe
Newsfile•Europe
GlobeNewswire•Europe
ACCESS Newswire•Europe
ACCESS Newswire•Europe